Hameln Company Profile
✉ Email this page to a colleague
What is the competitive landscape for HAMELN, and what generic and branded alternatives to HAMELN drugs are available?
HAMELN has three approved drugs.
Summary for Hameln
| US Patents: | 0 |
| Tradenames: | 3 |
| Ingredients: | 3 |
| NDAs: | 3 |
Drugs and US Patents for Hameln
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Hameln Rds Gmbh | GEMCITABINE HYDROCHLORIDE | gemcitabine hydrochloride | INJECTABLE;INJECTION | 090663-001 | Sep 10, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Hameln Pharma Plus | PENTETATE ZINC TRISODIUM | pentetate zinc trisodium | SOLUTION;INHALATION, INTRAVENOUS | 021751-001 | Aug 11, 2004 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| Hameln Rds Gmbh | GEMCITABINE HYDROCHLORIDE | gemcitabine hydrochloride | INJECTABLE;INJECTION | 090663-002 | Sep 10, 2012 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
